Thrombotic diseases, in particular cardiovascular and cerebrovascular thrombotic diseases, have become the top cause of death in the population of China, and their incidence has increased, seriously endangering human health.

China has been engaged in the R&D and manufacturing of semi-automatic coagulation analyzers for over a decade, and based on the data from the website of the NMPA, in 2024 and 2025 (as od 15 August), a total of 2 instruments from 2 manufacturers have obtained registration certificates...

PreventionGenetics said Thursday that it has been granted marketing authorization for its POMC/PCSK1/LEPR companion diagnostic as a Class II device by the US Food and Drug Administration.

Recently, the China Chamber of Commerce for Import and Export of Medicines and Health Products (CCCMHPIE) announced the second batch of Certificate of Export Commodity Brand list recommended by the chamber of Commerce for medical insurance in 2022.

Becton Dickinson has obtained the CE-IVD mark on a combined panel assay to detect SARS-CoV-2, influenza A and B, and respiratory syncytial virus. The assay runs on the firm's BD Max instrument and is now available in countries that recognize the CE mark, the firm said on Thursday.

Visby Medical said on Wednesday that it has added $35 million to its Series E financing round, bringing its total proceeds from the round to more than $135 million.

On June 28, the National Health Commission of the PRC released the "COVID-19 Prevention and Control Plan (Ninth Edition)". Compared with the eighth edition, the following revisions were made:

Roche announced on Tuesday that it has received CE marking for its Ventana DP 600 slide scanner for digital pathology.

Anitoa Systems announced on Wednesday that its PCR-based test for monkeypox has received CE marking.

As the grass-roots organization of CAST, Sansure Biotech attaches great importance to the construction of the enterprise association for science and technology, gives full play to the advantages of scientific and technological talents, innovation platforms, and good basic conditions.

Illumina said on Tuesday that it has invested an undisclosed amount in Time Boost Capital, a genomics venture fund that plans to match funding raised by startups participating in the UK-based version of Illumina's accelerator program.

Population genomics and viral surveillance company Helix said Tuesday that it has begun a new partnership with Texas' Memorial Hermann Health System to launch a new population health program targeting 100,000 individuals.